Cerus Corp (CERS) stock
CERSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 6/3022% below fair value
$1.94−0.18 (-8.49%)
Close on Nov 12, 2026Market cap $390.96MP/E –Yield –
Cerus EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Cerus
Cerus has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?